Article info

Download PDFPDF

Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment

Authors

  1. a andersoe{at}mskcc.org
  2. b postowm{at}mskcc.org
  3. c wolchokj{at}mskcc.org
  4. d youngr{at}mskcc.org
  5. e ballanga{at}mskcc.org
  6. f chant{at}mskcc.org
  7. g yamadaj{at}mskcc.org
  8. h (212) 639-5159 bealk{at}mskcc.org
View Full Text

Citation

Anderson ES, Postow MA, Wolchok JD, et al
Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment

Publication history

  • Received May 22, 2017
  • Accepted September 5, 2017
  • First published October 17, 2017.
Online issue publication 
October 17, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.